Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer research from target discovery to personalized medicine and cell therapy...

Treatment with TPN-101 showed clinical benefits on key clinical outcome measures, including the Revised ALS Functional Rating Scale (ALSFRS-R) and Slow Vital Capacity (SVC) TPN-101 also had...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the...

Industry Veteran Raj Ananthanpillai will discuss how to identity, prevent and investigate insider threats to safeguard organizational assets and share best practices and compliance strategies...

The 136th Canton Fair has concluded successfully, with the number of overseas buyers hitting a record high. The event significantly promoted high-quality development of international trade and...